Results 71 to 80 of about 23,381 (306)

Comments on "diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus" [PDF]

, 2015
Letter to ...
Assaf, Bedogni, Bedogni, Carlson, Colella, Fedele, Fedele, Fliefel, Graziani, Hoff, Holmdahl, Humphrey, Hutchinson, Jacobsen, Junquera, Khan, Kyrgidis, Liberati, Mawardi, Mucke, Nicolatou-Galitis, Noordzij, Otto, Patel, Pautke, Peters, Ruggiero, Ruggiero, Rupel, Schiodt, Schubert, Scully, Sharif, Sonnier, Stockmann, Then, Vescovi, Walter, Yarom, Yuan   +39 more
core   +1 more source

Pathogenesis and potential therapeutic targets of trichorhinophalangeal syndrome; lessons obtained from animal studies

Developmental Dynamics, EarlyView.
Abstract Trichorhinophalangeal syndrome (TRPS) is a rare genetic disease inherited in an autosomal dominant manner. It occurs in 1 in 100,000 people globally and is caused by several types of mutations of the TRPS1 gene. Since the first human patient was reported in 1966, typical and atypical pathologies, disease courses, and treatment case ...
Naoya Saeki, Rinna Kanai, Sayuri Tatsuta, Shinichi Kawaguchi, Masatsune Itoh, Shinsuke Ohba, Makoto Abe   +6 more
wiley   +1 more source

The effect of bisphosphonate discontinuation on the incidence of postoperative medication-related osteonecrosis of the jaw after tooth extraction

Journal of the Korean Association of Oral and Maxillofacial Surgeons, 2020
Objectives The discontinuation of bisphosphonate (BP) treatment before tooth extraction may induce medication-related osteonecrosis of the jaw (MRONJ).
Sang-Hoon Kang, Se-Jin Park, Moon-Key Kim   +2 more
semanticscholar   +1 more source

Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw

Dentistry Journal, 2021
Medication-related osteonecrosis of the jaw (MRONJ) frequently affects patients after treatments with bisphosphonates or denosumab, especially with high doses in patients with bone osteoporosis, neoplastic metastases, or possibly anti-angiogenic ...
Antonio Cortese, Antonio Casarella, Candace M. Howard, Pier Paolo Claudio   +3 more
doaj   +1 more source

Perioperative Piperacillin/Tazobactam Reduces Early Onset SSI in Preirradiated Patients Undergoing Microvascular Head and Neck Reconstruction

Head &Neck, EarlyView.
ABSTRACT Background Preirradiated patients undergoing microvascular head and neck reconstruction for tumor recurrence or osteoradionecrosis (ORN) face surgical site infection (SSI) rates exceeding 30%. The impact of perioperative extended‐spectrum antibiotic coverage remains unclear. This study hypothesizes that calculated prophylaxis with piperacillin/
Johannes G. Schuderer, Florian Hoferer, Jonas Eichberger, Mathias Fiedler, André Gessner, Stilla Bauernfeind, Maximilian Gottsauner, Felix Nieberle, Michael Maurer, Johannes K. Meier, Torsten E. Reichert, Tobias Ettl   +11 more
wiley   +1 more source

Osteonecrosis of the jaws in patients treated with bisphosphonates [PDF]

, 2012
The literature describes an increasing presence of bisphosphonate-induced osteonecrosis of the jaws (ONJ), characterized by the exposure for over 8 weeks of necrotic bone in the maxillofacial region, after bisphosphonate therapy, in the absence of ...
Ata-Ali Mahmud, Fadi, Ata-Ali Mahmud, Francisco Javier, Bagán Sebastián, José Vicente, Flichy Fernández, Antonio   +3 more
core   +1 more source

Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model [PDF]

Acta Cirúrgica Brasileira, 2016
PURPOSE : To evaluate a modified experimental model for medication-related osteonecrosis of the jaw (MRONJ) through the upper right central incisor extraction followed by intravenous bisphosphonate administration. METHODS: Forty five rats underwent the
Cláudia Curra, Camila Lopes Cardoso, Osny Ferreira Júnior, Marcos Martins Curi, Mariza Akemi Matsumoto, Bruno Cavalini Cavenago, Pâmela Letícia dos Santos, Joel Ferreira Santiago Júnior   +7 more
doaj   +1 more source

The chimeric ALT-vastus lateralis free flap in reconstruction of advanced BRONJ of the maxilla. [PDF]

, 2015
Introduction Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a dangerous complication of bisphosphonates, a class of pharmaceutical agents used in numerous bone disor- ders.
CILLINO, Michele, CORDOVA, Adriana, D'ARPA, Salvatore, DI LORENZO, Sara, Santanelli di Pompeo, F, TOIA, Francesca   +5 more
core   +1 more source

Soluble Sema4D From γδ T Cells Exerts Osteoblast Inhibition via Plexin‐B/mTOR Signalling Contributing to Pathogenesis of Bisphosphonate‐Related Osteonecrosis of the Jaws

Cell Proliferation, EarlyView.
Schematic summarizing the pathway of sSema4D from γδ T cells inhibiting osteoblast differentiation in BRONJ. ABSTRACT Bisphosphonate‐related osteonecrosis of the jaw (BRONJ) is a severe complication in patients undergoing long‐term bisphosphonate therapy, while our knowledge on the pathogenesis of BRONJ is far from sufficient.
Lingling Ou, Shijia Qiao, Zhuoyi Liao, Xiner Tan, Hui Huang, Zhiyan Zhou, Ruhui Luo, Weijun Zeng, Yan Yang, Zhongxuan Zhang, Jingchen Chen, Shengli Wang, Yiqin Jiang, Jianlei Hao, Yuqin Shen, Longquan Shao   +15 more
wiley   +1 more source

[Osteonecrosis of the jaws].

Revista medica de Chile, 2021
Medication-related osteonecrosis of the jaw is a disease where there is necrotic bone exposed or that can be explored by means of a fistula in the maxillofacial region. It has been associated with the use Biphosphonates and denosumab for osteoporosis. Although its etiology is unclear, it may be related to a decrease in bone turnover produced by these ...
Camila, Foncea, Kristine, von Bischhoffshausen, Cristián, Teuber, Hernán, Ramírez, Ignacio, Goñi, Cesar, Sánchez, Ignacio N, Retamal, Alex, Vargas   +7 more
openaire   +1 more source